Patent · US Active

Anti-PRLR antibody-drug conjugates (ADC) and uses thereof

US10112999B2 · kind B2 · utility

1Cited by
19References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2018
Grant dateOct 30, 2018
Priority date—
Expiry dateApr 6, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antibody drug conjugates that bind PRLR, in particular human PRLR, their methods of making, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.